Izmir University of Health Sciences Bozyaka Education and Research Hospital, Department of Neurology, Izmir, Turkey.
Izmir University of Health Sciences Tepecik Education and Research Hospital, Department of Pain, Izmir, Turkey | English | https://doi.org/10.18071/i.
Ideggyogy Sz. 2024 Mar 30;77(3-4):121-129. doi: 10.18071/isz.77.0121.
We aimed to investigate the difference of clinical and electrophysiological improvement between perineural corticosteroid injection therapy (PCIT) and perineural 5% dextrose injection therapy (5%PDIT) in carpal tunnel syndrome (CTS).
.Total of 92 wrists that were diagnosed as mild-to-moderate idiopathic CTS and completed their follow-up were included in our study. The severity of pain, symptom severity and functional status were assessed by visual analog scale (VAS) and the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) scores for treatment effectiveness. Randomized wrists were administered PCIT or 5%PDIT accompanied by ultrasound guidance. VAS, BCTQ scores and the electrophysiological study repeated before and after treatment at the 1st and 6th months after perineural injection therapies (PITs) were recorded.
.Compared with baseline data, within groups there was significant improvement in VAS, BCTQ severity and function scores at 1st and 6th months follow-up (all p < 0.001). Considerable advance were detected in the median sensory nerve conduction velocity (SNCV) when pretreatment values were compared with posttreatment first month in both groups (p = 0.01; p < 0.001, respectively). No significant change occurred in median distal motor latency (DML) values between the 1st and 6th months in the groups (p = 0.095; p = 0.113, respectively). No significant difference was observed between 5%PDIT and PCIT groups.
.Clinical and electrophysiologic improvement in CTS began from 1st month after PCIT and 5%PDIT. At the 6th month follow-up of the patients, 5%PDIT and PCIT had similar therapeutic effects. As a result, we can consider the replacement of PCIT with 5%PDIT in mild-to-moderate CTS patients especially in those who are hesitant because of the corticosteroid’s adverse effects.
.我们旨在研究神经周围皮质类固醇注射治疗(PCIT)和神经周围 5%葡萄糖注射治疗(5%PDIT)在腕管综合征(CTS)中的临床和电生理改善差异。
本研究共纳入 92 例被诊断为轻度至中度特发性 CTS 并完成随访的手腕。通过视觉模拟量表(VAS)和波士顿腕管综合征问卷(BCTQ)评分评估疼痛、症状严重程度和功能状态,以评估治疗效果。随机手腕接受 PCIT 或 5%PDIT 联合超声引导。记录神经周围注射治疗(PIT)后第 1、6 个月治疗前后的 VAS、BCTQ 评分和电生理研究。
与基线数据相比,两组患者在第 1 和第 6 个月随访时 VAS、BCTQ 严重程度和功能评分均有显著改善(均 P < 0.001)。两组患者的正中感觉神经传导速度(SNCV)在治疗前与治疗后第 1 个月均有显著提高(分别为 P = 0.01;P < 0.001)。两组患者的正中运动神经潜伏期(DML)值在第 1 个月至第 6 个月之间均无显著变化(分别为 P = 0.095;P = 0.113)。5%PDIT 和 PCIT 组之间无显著差异。
PCIT 和 5%PDIT 均可在治疗后第 1 个月开始改善 CTS 的临床和电生理状况。在第 6 个月的随访中,5%PDIT 和 PCIT 对患者的治疗效果相似。因此,我们可以考虑在轻度至中度 CTS 患者中用 5%PDIT 替代 PCIT,特别是在那些因皮质类固醇不良反应而犹豫不决的患者中。